Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorBlume, Michael S.en_US
dc.date.accessioned2012-06-07T02:33:24Z
dc.date.issued1995en_US
dc.identifier.citationCriminal Liability Under the Food, Drug, and Cosmetic Act (1995 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8846743
dc.description.abstractThe criminal provisions of the Federal Food, Drug, and Cosmetic Act (FDCA)' and the judicial interpretation thereof afford the Food and Drug Administration (FDA) great discretion, in determining both when and against whom criminal prosecution is warranted. Though it may employ a wide variety of enforcement mechanisms, the FDA has relied in recent years ever more heavily on criminal proceedings. Absent appropriate guidelines, however, extensive use of criminal sanctions to enforce the FDCA potentially leads to costly, inefficient, and unnecessary prosecutions. This paper attempts to define such guidelines in the context of criminal liability for corporate officers and employees. First, the paper will describe corporate liability under the FDCA. Next, it will utilize economic tools to propose guidelines to help determine when this liability is best imposed. Finally, it will examine the factual settings of two seminal cases in food and drug law using the proposed guidelines.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectDotterweichen
dc.subjectParken
dc.subjectprosecutionen
dc.titleCriminal Liability Under the Food, Drug, and Cosmetic Acten
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T02:33:24Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record